News

Tschugg, Switzerland – The Skywalk body weight support system has been successfully tested under clinical conditions at the Tschugg Rehabilitation Clinic. The results show that patients benefit from greater safety, improved balance training, and increased suitability for everyday use. The tests provided valuable insights for therapeutic use in neurological rehabilitation and confirmed the system's high practical value in everyday clinical practice.

We’re excited to announce that Autonomyo will be exhibiting at the 2026 APTA Combined Sections Meeting (APTA CSM) — the largest and most dynamic professional event for the physical therapy community in the world. APTA CSM brings together clinicians, researchers, educators, physical therapist assistants, students, and industry innovators for three days of learning, networking, and showcasing the future of rehabilitation.

Final clinical tests of Skywalk’s pre-production series have started at Rehaklinik Tschugg in Switzerland. From December 11, 2025 to January 8, 2026, the system is being evaluated in real-world neurorehabilitation settings as a key step toward market launch.

Skywalk shows consistent safety and usability across inpatient, outpatient, and home rehabilitation scenarios.

Join the movement and help bringing affordable and high quality rehabilitation to people with gait impairment.

Learn more about the market launch of Skywalk in 2026